ASPEN PHARMACARE HOLDINGS LIMITED - Grant and Acceptance of Share Awards by Directors, Prescribed Officers and The Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen

What this filing means

Aspen disclosed deferred incentive share awards to two directors, a prescribed officer, the company secretary, and a director and company secretary of Pharmacare Limited, a major subsidiary, under the Aspen Management Deferred Incentive Scheme. The six awards total 141,177 ordinary shares at a grant price of R161.73, based on the three-day VWAP to 2 November 2026, vesting after three, four and five years. The filing states no vesting conditions or performance hurdles, so how much of the reward depends on performance cannot be assessed.

Aspen is giving six senior people shares that they only receive over the next three to five years rather than cash now. The filing sets the grant price at R161.73 and says when the shares vest, but it does not say whether any of them depend on performance targets, so how much is tied to results cannot be judged from this notice. It also says nothing new about how the business is trading.